Related Experiment Video
Updated: Aug 23, 2025
14:20
Polymalic Acid-based Nano Biopolymers for Targeting of Multiple Tumor Markers: An Opportunity for Personalized Medicine?
Published on: June 13, 2014
16.8K
Targeting drugs to tumours using cell membrane-coated nanoparticles
Ronnie H Fang1,2, Weiwei Gao1,2, Liangfang Zhang3,4
1Department of NanoEngineering, Chemical Engineering Program, University of California San Diego, La Jolla, CA, USA.
Nature Reviews. Clinical Oncology
|October 28, 2022
Summary
Cell membrane-coated nanoparticles (CNPs) offer a promising nanomedicine approach to cancer therapy by improving drug delivery precision and reducing harm to healthy tissues. CNPs leverage cell membrane properties for enhanced biocompatibility, immune evasion, and tumor targeting, paving the way for clinical translation.
Area of Science:
- Nanomedicine
- Biomaterials Science
- Oncology
Background:
- Traditional cancer therapies like chemotherapy lack specificity, leading to damage in healthy tissues.
- Nanomedicine aims to improve drug delivery precision using nanoscale platforms.
- Cell membrane-coated nanoparticles (CNPs) are an emerging class of nanocarriers with significant biomedical potential.
Purpose of the Study:
- To review the development and applications of cell membrane-coated nanoparticles (CNPs) in cancer therapy.
- To detail the use of CNPs in drug delivery, phototherapy, and immunotherapy.
- To discuss the translational progress and future research needs for CNP clinical adoption.
Main Methods:
- Review of existing literature on cell membrane-coated nanoparticles.
- Analysis of CNP properties derived from natural cell membranes.
- Discussion of CNP applications in various cancer treatment modalities.
Main Results:
- CNPs utilize a synthetic core coated with natural cell membranes, conferring biomimetic properties.
- These properties include enhanced biocompatibility, immune evasion, and tumor targeting capabilities.
- CNP technology offers a streamlined approach to creating multifunctional nanoparticles.
Conclusions:
- CNPs represent a promising nanocarrier system for advanced cancer therapeutics.
- Their application spans drug delivery, phototherapy, and immunotherapy, with ongoing translational efforts.
- Further research is crucial for the successful clinical integration of CNPs in cancer treatment.
Related Concept Videos
02:57Targeted Cancer Therapies
7.8K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.8K
01:27Tumor Immunotherapy
639
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
639
01:26Targets for Drug Action: Overview
7.2K
Drugs target macromolecules to modify ongoing cellular processes. Primary drug targets include receptors, ion channels, transporters, and enzymes.
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
7.2K
01:15Drugs that Stabilize Microtubules
2.1K
Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
2.1K
02:50Combination Therapies and Personalized Medicine
5.0K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.0K